The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Summit Therapeutics has generated plenty of buzz in the biotech industry over the past two years. That's because the ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best future stocks to buy for the long term. On January 12, ...

Depending who you ask, AI-powered coding is either giving software developers an unprecedented productivity boost or churning ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...

Venture capitalists point to a surge in M&A and a glint of revival in the IPO arena as signs of better days ahead.

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...